Hu et al. have demonstrated that mortalin displays its oncogenic role in ovarian cancer by promoting tumor growth and migration/invasion via crucial pathways including cell-cycle and the MAPK–ERK signaling pathways [118]. This evidence concerns the gene HSPA9 and neoplasm.